Overview
- The World Health Organization has classified NB.1.8.1 as a Variant Under Monitoring after noting its growing global prevalence.
- CDC data and state health departments have confirmed cases in California, Ohio, Rhode Island, Hawaii, Washington and Virginia.
- Researchers report that NB.1.8.1 is more transmissible than earlier Omicron offshoots but does not appear to increase disease severity.
- The FDA will restrict updated COVID-19 booster shots this fall to seniors and people with specified medical conditions.
- Preliminary lab data indicate that an LP.8.1-based vaccine candidate could broaden protection against NB.1.8.1, though final fall booster strain decisions are pending.